SRLS Seracare Life Sciences (MM)

The law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of SeraCare Life Sciences, Inc. (“SeraCare”) (NASDAQ: SRLS) and other violations of state law by the board of directors of SeraCare relating to the proposed acquisition of the company by Linden Capital Partners (“Linden Capital”). The firm’s investigation seeks to determine, among other things, whether the board breached its fiduciary duties by failing to maximize shareholder value.

On February 13, 2012, SeraCare announced that it had entered into a definitive agreement providing for Linden Capital to acquire SeraCare for approximately $82 million. Under the terms of the agreement, SeraCare shareholders will receive $4.00 for each share of SeraCare common stock held. However, according to Yahoo! Finance, at least one analyst has set a high price target of $5.00 per share.

If you currently own shares of SeraCare and would like to learn more about the investigation being conducted by Brower Piven, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at hoffman@browerpiven.com, by calling (410) 415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.

Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024